Clinical Study
Is There a Role for Postmastectomy Radiation Therapy in Ductal Carcinoma In Situ?
Table 1
Patient characteristics.
| Clinical factor | Distribution |
| Age at diagnosis (years) | | (i) <40 | 20 (9.5%) | (ii) 41–50 | 86 (40.8%) | (iii) >50 | 105 (49.7%) | Race | | (i) White | 123 (58.3%) | (ii) Black | 30 (14.2%) | (iii) Others | 58 (27.5%) | Primary method of diagnosis | | (i) Breast Exam | 48 (22.7%) | (ii) Mammogram | 151 (71.5%) | (iii) Other imaging | 12 (5.7 %) | Nuclear Grade | | (i) Grade 1 | 22 (10.4%) | (ii) Grade 2 | 97 (45.9%) | (iii) Grade 3 | 92 (43.6%) | Final margins | | (i) Negative | 187 (88.6%) | (ii) Close (<1 mm)/Positive | 19 (9%)/5 (2.4%) | Receptor status | | (i) ER Positive | 42 (19.9%) | (ii) ER Negative | 107 (50.7%) | (iii) Unknown | 62 (29.4% ) |
|
|